Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp257 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Impact of TSH during the first trimester of pregnancy in obstetric and fetal complications: Usefulness of 2.5 mIU/l cut-off value

Soldevila Berta , Hernandez Marta , Lopez Carolina , Cacenarro Laura , Martinez-Barahona Maria , Palomera Elisabet , Rius Ferran , Lecube Albert , Pelegay Maria Jose , Garcia Jordi , Mauricio Didac , Puig-Domingo Manel

Background: An association of pregnancy outcomes with subclinical hypothyroidism have been reported, however, there still exists a strong controversy regarding whether subclinical hypothyroidism ought to be dealt with or not. The latest American Thyroid Association’s guideline gives support to a higher TSH upper reference range of 4 mIU/l than the one proposed a few years ago of 2.5 mIU/l for the first trimester of pregnancy, in the absence of local normal ranges of TSH. ...

ea0056p1091 | Thyroid (non-cancer) | ECE2018

Utility of 99 Tc-MIBI scintigraphy for the assessment of thyroid nodules with bethesda III cytologies

Perez Marta Sanchez , Rey Lola Santos , Tome Ana Gloria Villas , Castro Ma Jesus Diez , Coll Teresa Canela , Garcia Marta Hernandez , Mellah Chadia Mizab , Carrasquilla Liliana Patricia Gutierrez , Riu Ferran Rius

Introduction: Up to 30% of the thyroid nodules studied with fine needle aspiration biopsy (FNAB) are reported as Bethesda III, a category that does not rule out malignancy. One technique that could help to decide if there is a surgical indication is (99 m) Tc-sestaMIBI scintigraphy (MIBI).Material and methods: All patients with a Bethesda III result were prospectively included, and 99 Tc-MIBI scintigraphy was performed prior to surgery. All exams, includ...